Depressive episode incidence in patients with chronic hepatitis c treated with pegylated interferon and ribavirin
Arq. gastroenterol; 53 (1), 2016
ABSTRACT Background The effectiveness of antiviral therapy with pegylated interferon and ribavirin for chronic hepatitis C is far from ideal and presents several adverse events. Among such events, there is the depressive episode that can even lead to treatment discontinuity Objective Analyze the incide...
Antivirales/efectos adversos, Antivirales/uso terapéutico, Estudios de Cohortes, Depresión/inducido químicamente, Depresión/psicología, Quimioterapia Combinada, Hepatitis C Crónica/tratamiento farmacológico, Hepatitis C Crónica/psicología, Interferón alfa-2, Interferón-alfa/efectos adversos, Interferón-alfa/uso terapéutico, Persona de Mediana Edad, Polietilenglicoles/efectos adversos, Polietilenglicoles/uso terapéutico, Estudios Prospectivos, Proteínas Recombinantes/efectos adversos, Proteínas Recombinantes/uso terapéutico, Ribavirina/efectos adversos, Ribavirina/uso terapéutico, Factores Sociológicos